DOLLAR LABS Trademark

Trademark Overview


On Thursday, September 25, 2003, a trademark application was filed for DOLLAR LABS with the United States Patent and Trademark Office. The USPTO has given the DOLLAR LABS trademark a serial number of 76546951. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 13, 2011. This trademark is owned by L. Perrigo Company. The DOLLAR LABS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, acid reducers, analgesics, antacids, anti-diarrheals, anti-gas preparations, antihistamines, chemically activated heat releasing wraps for therapeutic purposes, cold and allergy relief medications, cough suppressants, diet pills/tablets, dietary supplements, expectorants, fungicidal agents in the form of suppositories and creams, gastrointestinal treatment preparations, hair re-growth treatments, hemorrhoid treatment preparations, laxatives, migraine treatment preparations, nutritional drinks, nasal spray preparations, nasal decongestants, nutritional supplements, ovulation test kits, pain reliever and fever reducer medications, pregnancy test kits for home use, sleep aid pills/tablets, and smoking cessation aids
dollar labs

General Information


Serial Number76546951
Word MarkDOLLAR LABS
Filing DateThursday, September 25, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 13, 2011
Registration Number2892910
Registration DateTuesday, October 12, 2004
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 20, 2004

Trademark Statements


Disclaimer with Predetermined Text"LABS"
Goods and ServicesPharmaceutical preparations, namely, acid reducers, analgesics, antacids, anti-diarrheals, anti-gas preparations, antihistamines, chemically activated heat releasing wraps for therapeutic purposes, cold and allergy relief medications, cough suppressants, diet pills/tablets, dietary supplements, expectorants, fungicidal agents in the form of suppositories and creams, gastrointestinal treatment preparations, hair re-growth treatments, hemorrhoid treatment preparations, laxatives, migraine treatment preparations, nutritional drinks, nasal spray preparations, nasal decongestants, nutritional supplements, ovulation test kits, pain reliever and fever reducer medications, pregnancy test kits for home use, sleep aid pills/tablets, and smoking cessation aids

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 13, 2011
Primary Code005
First Use Anywhere DateMonday, March 22, 2004
First Use In Commerce DateMonday, March 22, 2004

Trademark Owner History


Party NameL. Perrigo Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAllegan, MI 49010

Party NameL. Perrigo Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAllegan, MI 49010

Party NameL. Perrigo Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAllegan, MI 49010

Trademark Events


Event DateEvent Description
Friday, May 13, 2011CANCELLED SEC. 8 (6-YR)
Tuesday, October 12, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2004NOTICE OF PUBLICATION
Monday, May 17, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 17, 2004USE AMENDMENT ACCEPTED
Wednesday, May 5, 2004EXAMINER'S AMENDMENT MAILED
Wednesday, April 21, 2004AMENDMENT TO USE PROCESSING COMPLETE
Thursday, April 15, 2004USE AMENDMENT FILED
Thursday, April 15, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 20, 2004ASSIGNED TO EXAMINER
Thursday, April 15, 2004PAPER RECEIVED